NCT02369692

Embolization Procedures in the Peripheral Vasculature Using the Magellan™ Robotic System

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 15 (actual)
• Sponsor: Hansen Medical · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this prospective study is to gather procedural use and safety data on the initial use of the Magellan Robotic System with the Magellan Robotic Catheter 6 Fr, Vascular Accessories 6 Fr and Microcatheter Driver This study will focus on, but not be limited to, endovascular embolization procedures in the peripheral vascular, for example, embolization of the splenic and hepatic arteries, uterine arterial embolization (UAE), prostatic arterial embolization (PAE), and trans-arterial chemoembolization (TACE). The data will be analyzed for medical education, societal presentation and/or publication by the investigator.

Detailed description

The primary objectives of this study are to evaluate the safety and clinical performance of the Magellan Robotic System with the 6 Fr catheter, Vascular Accessories 6 Fr and Microcatheter Driver in patients who are indicated for an embolization procedure or other endovascular procedure in the peripheral vasculature.

Conditions

• Peripheral Vascular Disease

Interventions

Type	Name	Description
DEVICE	Magellan Robotic 6 Fr Catheter	The Hansen Medical Magellan™ Robotic Catheter 6 Fr (Magellan™)

Timeline

• Start date: 2014-04-01
• Primary completion: 2016-08-01
• Completion: 2016-08-01
• First posted: 2015-02-24
• Last updated: 2018-03-01

Locations

1 site across 1 country: France